Global Hepatitis Therapeutics Market Research Report 2023

Report ID: 1974654 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hepatitis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hepatitis Vaccine
        1.2.3 Anti-Viral Drugs
    1.3 Market by Application
        1.3.1 Global Hepatitis Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hepatitis A
        1.3.3 Hepatitis B
        1.3.4 Hepatitis C
        1.3.5 Alcoholic Hepatitis
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hepatitis Therapeutics Market Perspective (2017-2028)
    2.2 Hepatitis Therapeutics Growth Trends by Region
        2.2.1 Hepatitis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hepatitis Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Hepatitis Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Hepatitis Therapeutics Market Dynamics
        2.3.1 Hepatitis Therapeutics Industry Trends
        2.3.2 Hepatitis Therapeutics Market Drivers
        2.3.3 Hepatitis Therapeutics Market Challenges
        2.3.4 Hepatitis Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hepatitis Therapeutics Players by Revenue
        3.1.1 Global Top Hepatitis Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Hepatitis Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Hepatitis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hepatitis Therapeutics Revenue
    3.4 Global Hepatitis Therapeutics Market Concentration Ratio
        3.4.1 Global Hepatitis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hepatitis Therapeutics Revenue in 2021
    3.5 Hepatitis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Hepatitis Therapeutics Product Solution and Service
    3.7 Date of Enter into Hepatitis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis Therapeutics Breakdown Data by Type
    4.1 Global Hepatitis Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Hepatitis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Hepatitis Therapeutics Breakdown Data by Application
    5.1 Global Hepatitis Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Hepatitis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hepatitis Therapeutics Market Size (2017-2028)
    6.2 North America Hepatitis Therapeutics Market Size by Country (2017-2022)
    6.3 North America Hepatitis Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hepatitis Therapeutics Market Size (2017-2028)
    7.2 Europe Hepatitis Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Hepatitis Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hepatitis Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Hepatitis Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hepatitis Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hepatitis Therapeutics Market Size (2017-2028)
    9.2 Latin America Hepatitis Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Hepatitis Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hepatitis Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Gilead
        11.1.1 Gilead Company Detail
        11.1.2 Gilead Business Overview
        11.1.3 Gilead Hepatitis Therapeutics Introduction
        11.1.4 Gilead Revenue in Hepatitis Therapeutics Business (2017-2022)
        11.1.5 Gilead Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Hepatitis Therapeutics Introduction
        11.2.4 Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 Bristol-Myers Squibb Company
        11.3.1 Bristol-Myers Squibb Company Company Detail
        11.3.2 Bristol-Myers Squibb Company Business Overview
        11.3.3 Bristol-Myers Squibb Company Hepatitis Therapeutics Introduction
        11.3.4 Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Company Recent Development
    11.4 Merck & Co.Inc.
        11.4.1 Merck & Co.Inc. Company Detail
        11.4.2 Merck & Co.Inc. Business Overview
        11.4.3 Merck & Co.Inc. Hepatitis Therapeutics Introduction
        11.4.4 Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2017-2022)
        11.4.5 Merck & Co.Inc. Recent Development
    11.5 AbbVie Inc.
        11.5.1 AbbVie Inc. Company Detail
        11.5.2 AbbVie Inc. Business Overview
        11.5.3 AbbVie Inc. Hepatitis Therapeutics Introduction
        11.5.4 AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2017-2022)
        11.5.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Hepatitis Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hepatitis Vaccine
    Table 3. Key Players of Anti-Viral Drugs
    Table 4. Global Hepatitis Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Hepatitis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hepatitis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hepatitis Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Hepatitis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hepatitis Therapeutics Market Share by Region (2023-2028)
    Table 10. Hepatitis Therapeutics Market Trends
    Table 11. Hepatitis Therapeutics Market Drivers
    Table 12. Hepatitis Therapeutics Market Challenges
    Table 13. Hepatitis Therapeutics Market Restraints
    Table 14. Global Hepatitis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hepatitis Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Hepatitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2021)
    Table 17. Ranking of Global Top Hepatitis Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hepatitis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hepatitis Therapeutics Product Solution and Service
    Table 21. Date of Enter into Hepatitis Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hepatitis Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Hepatitis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hepatitis Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hepatitis Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Hepatitis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hepatitis Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Hepatitis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Hepatitis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Gilead Company Detail
    Table 42. Gilead Business Overview
    Table 43. Gilead Hepatitis Therapeutics Product
    Table 44. Gilead Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Gilead Recent Development
    Table 46. Johnson & Johnson Company Detail
    Table 47. Johnson & Johnson Business Overview
    Table 48. Johnson & Johnson Hepatitis Therapeutics Product
    Table 49. Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Johnson & Johnson Recent Development
    Table 51. Bristol-Myers Squibb Company Company Detail
    Table 52. Bristol-Myers Squibb Company Business Overview
    Table 53. Bristol-Myers Squibb Company Hepatitis Therapeutics Product
    Table 54. Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Bristol-Myers Squibb Company Recent Development
    Table 56. Merck & Co.Inc. Company Detail
    Table 57. Merck & Co.Inc. Business Overview
    Table 58. Merck & Co.Inc. Hepatitis Therapeutics Product
    Table 59. Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Merck & Co.Inc. Recent Development
    Table 61. AbbVie Inc. Company Detail
    Table 62. AbbVie Inc. Business Overview
    Table 63. AbbVie Inc. Hepatitis Therapeutics Product
    Table 64. AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. AbbVie Inc. Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatitis Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Hepatitis Vaccine Features
    Figure 3. Anti-Viral Drugs Features
    Figure 4. Global Hepatitis Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Hepatitis A Case Studies
    Figure 6. Hepatitis B Case Studies
    Figure 7. Hepatitis C Case Studies
    Figure 8. Alcoholic Hepatitis Case Studies
    Figure 9. Others Case Studies
    Figure 10. Hepatitis Therapeutics Report Years Considered
    Figure 11. Global Hepatitis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Hepatitis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hepatitis Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Hepatitis Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Hepatitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Hepatitis Therapeutics Revenue in 2021
    Figure 17. North America Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Hepatitis Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Hepatitis Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Hepatitis Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Hepatitis Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Hepatitis Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Gilead Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022)
    Figure 47. Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022)
    Figure 48. Merck & Co.Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022)
    Figure 49. AbbVie Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead
Johnson & Johnson
Bristol-Myers Squibb Company
Merck & Co.Inc.
AbbVie Inc.
Frequently Asked Questions
Hepatitis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports